Creative Planning’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
52,938
-9,151
| -15% | -$28.3K | ﹤0.01% | 3288 |
|
|
2025
Q1 | $217K | Buy |
62,089
+13,745
| +28% | +$48K | ﹤0.01% | 2990 |
|
|
2024
Q4 | $158K | Sell |
48,344
-1,156
| -2% | -$3.78K | ﹤0.01% | 3036 |
|
|
2024
Q3 | $191K | Buy |
49,500
+5,989
| +14% | +$23.1K | ﹤0.01% | 2855 |
|
|
2024
Q2 | $134K | Buy |
43,511
+13,651
| +46% | +$42.2K | ﹤0.01% | 2766 |
|
|
2024
Q1 | $77K | Buy |
29,860
+15,294
| +105% | +$39.5K | ﹤0.01% | 2728 |
|
|
2023
Q4 | $36.4K | Buy |
+14,566
| New | +$36.4K | ﹤0.01% | 2651 |
|
|
2021
Q2 | – | Sell |
-24,210
| Closed | -$81K | – | 1978 |
|
|
2021
Q1 | $81K | Sell |
24,210
-2,493
| -9% | -$8.34K | ﹤0.01% | 2213 |
|
|
2020
Q4 | $95K | Buy |
+26,703
| New | +$95K | ﹤0.01% | 1974 |
|
|
2020
Q3 | – | Sell |
-32,748
| Closed | -$60K | – | 1946 |
|
|
2020
Q2 | $60K | Buy |
+32,748
| New | +$60K | ﹤0.01% | 1706 |
|
|
2017
Q3 | – | Sell |
-1,050
| Closed | -$4K | – | 1864 |
|
|
2017
Q2 | $4K | Buy |
1,050
+50
| +5% | +$190 | ﹤0.01% | 4001 |
|
|
2017
Q1 | $3K | Sell |
1,000
-500
| -33% | -$1.5K | ﹤0.01% | 4056 |
|
|
2016
Q4 | $4K | Buy |
1,500
+500
| +50% | +$1.33K | ﹤0.01% | 3942 |
|
|
2016
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 3957 |
|
|
2016
Q2 | $3K | Sell |
1,000
-450
| -31% | -$1.35K | ﹤0.01% | 3764 |
|
|
2016
Q1 | $6K | Sell |
1,450
-50
| -3% | -$207 | ﹤0.01% | 3421 |
|
|
2015
Q4 | $7K | Hold |
1,500
| – | – | ﹤0.01% | 3426 |
|
|
2015
Q3 | $9K | Sell |
1,500
-11,000
| -88% | -$66K | ﹤0.01% | 3215 |
|
|
2015
Q2 | $148K | Buy |
12,500
+12,450
| +24,900% | +$147K | ﹤0.01% | 916 |
|
|
2015
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 3878 |
|
|
2014
Q4 | $1K | Sell |
50
-500
| -91% | -$10K | ﹤0.01% | 3826 |
|
|
2014
Q3 | $12K | Buy |
+550
| New | +$12K | ﹤0.01% | 2794 |
|